AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Injection Drug Use

Califf, FDA top officials call for sweeping review of agency opioids policies

FDA

Editor’s Note: Reducing opioid misuse not only reduces deaths from overdose but is also key to reducing new HIV and viral hepatitis infections among persons who inject drugs. For more on the link between opioid misuse, HIV and viral hepatitis, see this CDC report. In response to the opioid abuse epidemic, today Dr. Robert Califf, the…

Slides Now Available! 2015 APHA Special Session: The Changing Epidemiology of Viral Hepatitis – Hepatitis C Emerging Trends and Disparities

apha-logo

In November at the 143rd American Public Health Association (APHA) Annual Meeting & Exposition, OHAIDP facilitated a special session, “The Changing Epidemiology of Viral Hepatitis – Hepatitis C Emerging Trends and Disparities.” Michelle Moses-Eisenstein, MPH, the session organizer and moderator, opened the 90-minute Special Epidemiology session and introduced the speakers. Scott Holmberg, MD, MPH, Chief,…

CDC Syringe Services Programs Statement

CDC Logo

Congress has given states and local communities, under limited circumstances, the opportunity to use federal funds to support certain components of syringe services programs. These programs provide sterile injection equipment and may also link individuals to services including HIV and hepatitis C testing and care for those infected, substance abuse treatment, and overdose prevention. Outbreaks…

In Recognition of World Hepatitis Day

The White House

 “If we continue to box people in because of their medical conditions, to stigmatize individuals because of their health, and treat diseases as discrete conditions, we will never reach our common goals of health and wellbeing.” – Michael Botticelli, Director of National Drug Control Policy Today, as we observe World Hepatitis Day, it is important…

The Importance of Integrating HIV and Addiction Treatment

NIDA logo

Great progress has been made in reducing the number of new HIV infections and transforming the disease into a manageable and livable condition, but we still have some way to go to achieve an AIDS-free world. Injection drug use is still creating new, local epidemics, and the ways substance use disorders and HIV are intertwined…

Now Available! Archived Webinar on Hepatitis C Prevention Opportunities Among People Who Inject Drugs

hepatitis title slide crop3

Last month, as part of ongoing efforts to increase awareness of viral hepatitis among populations at risk, we were pleased to host a webinar Hepatitis C Prevention Opportunities Among People Who Inject Drugs: Confronting the Growing Epidemic. Participants learned about trends in hepatitis C, new tools, and prevention messages, and also reviewed hepatitis C prevention…

National Hepatitis Testing Day: Ask the Expert, Corinna Dan

Corinna Dan

National Hepatitis Testing Day in the United States is part of an educational initiative of CDC’s Division of  Viral Hepatitis and the U.S. Department of Health & Human Services’ Combating the Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care & Treatment of Viral Hepatitis, Updated 2014-2016 . Corinna Dan, R.N., M.P.H., is…

Register Today for Webinar on Hepatitis C Prevention for People Who Inject Drugs

AIDS.gov

The HHS Office of HIV/AIDS and Infectious Disease Policy (OHAIDP) will host a webinar, Hepatitis C Prevention Opportunities among People Who Inject Drugs – Confronting the Growing Epidemic, on Tuesday, April 28, 2015 – 1:00-2:00 PM (ET). According to the Centers for Disease Control and Prevention, reported cases of acute hepatitis C (HCV) have increased…